Extendicare (TSE:EXE - Get Free Report) will issue its quarterly earnings data after the market closes on Tuesday, November 12th.
Extendicare (TSE:EXE - Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported C$0.29 earnings per share (EPS) for the quarter. The business had revenue of C$348.48 million for the quarter, compared to the consensus estimate of C$360.20 million. Extendicare had a net margin of 4.28% and a return on equity of 60.00%.
Extendicare Trading Up 0.2 %
Shares of Extendicare stock traded up C$0.02 on Tuesday, reaching C$9.14. The company had a trading volume of 91,320 shares, compared to its average volume of 130,404. The firm's 50 day moving average price is C$9.10 and its two-hundred day moving average price is C$8.03. The firm has a market cap of C$762.92 million, a PE ratio of 13.38 and a beta of 1.26. Extendicare has a 52-week low of C$5.75 and a 52-week high of C$9.52. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Friday, November 15th. Stockholders of record on Thursday, October 31st will be paid a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 5.25%. The ex-dividend date is Thursday, October 31st. Extendicare's dividend payout ratio (DPR) is 70.59%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on EXE shares. Royal Bank of Canada boosted their price target on shares of Extendicare from C$8.50 to C$9.50 in a research note on Monday, August 19th. TD Securities upped their target price on shares of Extendicare from C$9.00 to C$9.50 and gave the stock a "hold" rating in a research note on Wednesday, September 4th.
View Our Latest Analysis on Extendicare
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
See Also
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
